Literature DB >> 12483647

Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization.

Masahiro Fukuzawa1, Hiroaki Sugiura, Tsugumichi Koshinaga, Taro Ikeda, Noritugu Hagiwara, Tatsuo Sawada.   

Abstract

BACKGROUND/
PURPOSE: Although angiogenic factors may play an important role in the biology of neuroblastoma, which frequently spreads hematogenously, the mechanism remains unclear. The authors studied tumor progression and invasion from the perspective of angiogenesis and sought to understand the features of this type of tumor.
METHODS: Thirty-one specimens were resected from patients with neuroblastoma and the expression of vascular endothelial growth factor (VEGF), and its receptor (Flk-1) was examined using immunohistochemistry. The authors looked for correlations among the expressions of VEGF and its receptor with various clinicopathologic factors. In addition, they examined the expression and location of VEGF and Flk-1 mRNA in 10 primary neuroblastoma using in situ hybridization.
RESULTS: Both in situ hybridization and immunohistochemistry showed the presence of VEGF expression within the neuroblastoma cells. We found VEGF mRNA in neuroblastoma cells but not vascular endothelial cells according to in situ hybridization. Further, Flk-1 mRNA was present both in neuroblastoma cells and vascular endothelial cells. The level of VEGF expression was higher in unfavorable histology, using the criteria of Shimada, than in favorable histology.
CONCLUSION: The authors suggest that paracrine and autocrine systems are involved in the angiogenesis of neuroblastoma, and the expression of VEGF correlates with the prognosis in neuroblastoma. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483647     DOI: 10.1053/jpsu.2002.36712

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Bombesin induces angiogenesis and neuroblastoma growth.

Authors:  Junghee Kang; Titilope A Ishola; Naira Baregamian; Joshua M Mourot; Piotr G Rychahou; B Mark Evers; Dai H Chung
Journal:  Cancer Lett       Date:  2007-03-26       Impact factor: 8.679

Review 2.  Pharmacologic management of high-risk neuroblastoma in children.

Authors:  Veena R Ganeshan; Nina F Schor
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

3.  The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study.

Authors:  Feifei Sun; Suying Lu; Zijun Zhen; Jia Zhu; Juan Wang; Junting Huang; Yu Zhang; Hui Li; Ruiqing Cai; Meiling Liu; Liuhong Wu; Xiaofei Sun; Yizhuo Zhang
Journal:  Cancer Manag Res       Date:  2020-07-22       Impact factor: 3.989

4.  Protein kinase C regulates bombesin-induced rapid VEGF secretion in neuroblastoma cells.

Authors:  Cameron Schlegel; Pritha Paul; Sora Lee; Kwang Woon Kim; Nadja Colon; Jingbo Qiao; Dai H Chung
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

5.  N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.

Authors:  J Kang; P G Rychahou; T A Ishola; J M Mourot; B M Evers; D H Chung
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

6.  Vascular endothelial growth factor in children with neuroblastoma: a retrospective analysis.

Authors:  Gordana Jakovljević; Srana Culić; Jasminka Stepan; Aleksandra Bonevski; Sven Seiwerth
Journal:  J Exp Clin Cancer Res       Date:  2009-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.